beta-lactams has been researched along with Infections, Klebsiella in 217 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (1.38) | 18.7374 |
| 1990's | 10 (4.61) | 18.2507 |
| 2000's | 61 (28.11) | 29.6817 |
| 2010's | 133 (61.29) | 24.3611 |
| 2020's | 10 (4.61) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Li, M; Lu, H; Tian, Y; Wang, M; Xu, L; Zhang, F | 1 |
| Barata, RR; Brasiliense, DM; Camargo, DS; Carneiro, ICRS; Costa, CJS; Dutra, LMG; Lobato, A; Martins, WMBS; Souza, CO | 1 |
| Ding, Y; Li, Z; Liu, J; Liu, S; Xu, Y; Zeng, Z | 1 |
| Nishida, S; Ono, Y | 1 |
| Feng, J; Liang, L; Sun, Q; Tong, Y; Xiang, R; Zhai, F | 1 |
| Chou, SH; Chuang, C; Huang, YH; Lin, YT; Tsai, TH; Wang, FD | 1 |
| Furlan, JPR; Gonzalez, IHL; Lopes, R; Ramos, PL; Stehling, EG; von Zeska Kress, MR | 1 |
| Abd El-Aziz, AM; Abdelmegeed, ES; Hassan, R; Khalifa, SM | 1 |
| Bharathwaj, M; Lithgow, T; Palmer, T; Stubenrauch, CJ; Vadlamani, G; Webb, CT | 1 |
| Bhagwat, S; Joshi, P; Patel, M; Shrivastava, R | 1 |
| Görür, K; İsmi, O; Özcan, C; Vayisoğlu, Y; Yeşilova, M | 1 |
| Abderrahim, A; Bentakouk, MC; Dekhil, M; Djahmi, N; Kirane-Gacemi, D; Lavigne, JP; Nedjai, S; Pantel, A; Pujol, C; Sotto, A | 1 |
| Baroncelli, S; Bartoloni, A; Farese, A; Luise, F; Mancini, A; Nozzoli, C; Pieralli, F; Rossolini, GM; Sammicheli, L | 1 |
| Tamma, PD; Villegas, MV | 1 |
| Antonelli, M; Arcadipane, A; Capitanio, G; Cutuli, SL; De Pascale, G; Di Carlo, D; Di Gravio, V; Di Stefano, R; Martucci, G; Montini, L; Panarello, G; Polidori, P; Spanu, T; Vallecoccia, MS | 1 |
| Almirante, B; Campany, D; Fàbrega, A; Fox, ML; González-López, JJ; Larrosa, N; Miguel, L; Mir, A; Piedra-Carrasco, N; Ruiz-Camps, I; Viñado, B | 1 |
| Lutgens, SP; Mollers, M; Schneeberger, PM; Schoffelen, AF; Suijkerbuijk, AWM | 1 |
| Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Horvath, E; Kazmierczak, KM; Sahm, DF; Wise, MG; Young, K | 1 |
| Avison, MB; Findlay, J; Heesom, KJ; Takebayashi, Y; Wan Nur Ismah, WAK | 1 |
| Al-Bustan, SA; Alkhudhairy, MK; Alshadeedi, SMJ; Ghasemian, A; Mahmood, SS | 1 |
| Alfonso, C; Berger, MA; Cejas, D; De Paulis, A; Elena, A; Fernández-Canigia, L; Guevara Nuñez, D; Gutkind, G; Magariños, F; Radice, M; Sevillano Platero, P | 1 |
| Brennan-Krohn, T; Kirby, JE | 1 |
| Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I | 1 |
| Berrazeg, M; Drissi, M; Medjahed, L; Rolain, JM | 1 |
| Crandon, JL; Hagihara, M; Nicolau, DP; Urban, C | 1 |
| Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M | 1 |
| Chen, Q; Rui, Y; Sun, J; Wang, F; Wang, Q; Wu, K; Yu, S; Zheng, F | 1 |
| Bonten, MJ; Cohen Stuart, JW; Dorigo-Zetsma, JW; Frakking, FN; Kluytmans, JA; Leverstein-van Hall, MA; Lutgens, SP; Prins, JM; Rottier, WC; Thijsen, SF; van Hattem, JM; van Hees, BC; Verbon, A; Vlaminckx, BJ | 1 |
| Chaudhary, M; Kumar, S; Payasi, A | 1 |
| Chung, C; Desjardins, M; Ellis, C; Melano, RG; Patel, SN; Tijet, N; Toye, B | 1 |
| Crandon, JL; Nicolau, DP; Nordmann, P; Wiskirchen, DE | 1 |
| Chatzipantazi, V; Koumaki, V; Markou, F; Poulou, A; Tsakris, A; Voulgari, E; Vrioni, G; Xidopoulos, G | 1 |
| Machado, E; Novais, Â; Peixe, L; Rodrigues, C | 1 |
| Arena, F; Bagnoli, F; Becucci, E; Buonocore, G; Conte, V; D'Andrea, MM; Giani, T; Montagnani, F; Rossolini, GM; Zanchi, A; Zanelli, G | 1 |
| Kim, SY; Ko, KS; Rhee, JY; Shin, SY | 1 |
| Chen, H; Li, Z; Ni, M; Wang, H; Wang, Q; Wang, X; Xu, X; Yang, P; Zhao, C | 1 |
| Evans, NJ; Fick, JC; Maciuca, IE; Timofte, D; Wattret, A; Williams, H; Williams, NJ | 1 |
| Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C | 1 |
| Burnham, CA; Frobel, RA; Herrera, ML; Wickes, BL | 1 |
| Cornaglia, G; Kocsis, E; Lo Cascio, G; Mazzariol, A; Piccoli, M | 1 |
| Attallah, M; Gomaa, N; Kamel, N; Metwally, L | 1 |
| Chen, H; He, W; Li, H; Liu, J; Wang, H; Wang, Q; Wang, X; Wang, Z; Zhang, F; Zhang, Y; Zhao, C | 1 |
| Alvarado, A; Carrero, G; Fajardo, C; Gómez, F; Jiménez, A | 1 |
| Chen, CH; Chen, JB; Chiu, CH; Chuang, FR; Lee, CT; Liu, HT; Wu, CH; Yang, CC | 1 |
| Absar, MM; Al Hedaithy, MA; Al Subaie, SS; Arshad, MZ; Habib, HA; Manneh, K; Murray, TS; Sayyed, SB; Shakoor, Z; Somily, AM | 1 |
| Danishuddin, M; Faheem, M; Khan, A; Khan, AU | 1 |
| Bresan, S; Edel, B; Erhard, M; Pfister, W; Rödel, J; Sachse, S; Saupe, A | 1 |
| Albano, RM; Asensi, MD; Borghi, M; Carvalho-Assef, AP; Lopes, JC; Marques, EA; Oliveira, JC; Pereira, PS; Silveira, MC | 1 |
| Bastian, S; Breurec, S; Creton, E; Dortet, L; Malpote, E; Martino, F; Nordmann, P; Thiery, G | 1 |
| Hara, T; Horiyama, T; Kanazawa, S; Maki, H; Sato, T; Yamaguchi, T | 1 |
| Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA | 1 |
| Baquir, B; de la Fuente-Núñez, C; Faria-Junior, C; Franco, OL; Hancock, RE; Ribeiro, SM | 1 |
| Badal, RE; Bouchillon, SK; Hackel, MA; Hoban, DJ; Kazmierczak, KM; Lob, SH | 1 |
| Gentry, CA; Williams, RJ | 1 |
| Adler, A; Blum, SE; Carmeli, Y; Fallach, N; Hussein, O; Klement, E; Schwaber, MJ; Sturlesi, N; Zilberman-Barzilai, D | 1 |
| Cipolla, A; D'Abramo, A; D'Agostino, C; Gizzi, F; Iannetta, M; Mascellino, MT; Mastroianni, CM; Oliva, A; Russo, G; Tierno, F; Trinchieri, V; Vullo, V | 1 |
| Giske, CG; Iversen, A; Nematzadeh, S; Shahcheraghi, F | 1 |
| Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K | 1 |
| Arakawa, Y; Fujita, A; Jin, W; Kimura, K; Mikamo, H; Suematsu, H; Wachino, J; Yamada, K; Yamagishi, Y; Yokoyama, S | 1 |
| Cprek, JB; Gallagher, JC | 1 |
| Ayaz, T; Kara, E; Sahin, OZ; Sahutoglu, T; Tufekci, A; Yildirim, S | 1 |
| Fernando de Oliveira, C; Mohr, G; Pereira da Rocha, M; Rieger, A; Vargas da Silva, L | 1 |
| Barbosa, FC; Pinto, VP; Rocha, FR | 1 |
| Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH | 1 |
| Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I | 1 |
| Hennequin, C; Robin, F | 1 |
| Arce Gil, Z; Flores Clavo, R; Rivera-Jacinto, M; Rodríguez-Ulloa, C; Serquén López, L | 1 |
| Arends, JP; Deurenberg, RH; Friedrich, AW; Grundmann, H; Lo-Ten-Foe, J; Lokate, M; Raangs, EG; Rossen, JW; Tepper, M; Zhou, K | 1 |
| Caio, C; Gona, F; Mezzatesta, ML; Salerno, I; Stefani, S; Zingali, T | 1 |
| Agyekum, A; Ai, X; Fajardo-Lubián, A; Ginn, AN; Guo, X; Iredell, JR; Partridge, SR; Turnidge, J; Zong, Z | 1 |
| Kazanji, N; Klein, RE; Le, J; Lohani, S; Mertens, AN | 1 |
| Aberkane, S; Bouzinbi, N; Carriere, C; Decré, D; Godreuil, S; Jean-Pierre, H; Kissou, A; Nacro, B; Ouédraogo, AS; Ouédraogo, R; Poda, A; Sanou, S; Van De Perre, P | 1 |
| Feng, Y; Li, J; Li, S; Sun, H; Xu, W; Xue, G; Yan, C; Zhao, H | 1 |
| Nicolau, DP; Sutherland, CA; Verastegui, JE | 1 |
| Alikhani, MY; Khodaparast, S; Moghadam, MK; Mousavi, SF; Mozaffari Nejad, AS; Shahcheraghi, F | 1 |
| Chelaghma, W; Kassah-Laouar, A; Loucif, L; Messala, A; Rolain, JM; Saidi, M | 1 |
| Bitterman, R; Geffen, Y; Paul, M; Polak, D | 1 |
| Beyrouthy, R; Bonnet, R; Hamze, M; Robin, F | 1 |
| Battikh, H; Dekhili, A; Fendri, C; Harchay, C; Kechrid, F; Khazar, K; Masmoudi, A; Zribi, M | 1 |
| Bhattacharjee, A; Chakravarty, A; Choudhury, MD; Choudhury, S; Dhar, D; Ingti, B; Laskar, MA; Maurya, AP; Paul, D; Talukdar, AD | 1 |
| Biswal, S; Ghosh, AS; Issa, B; Kar, D; Kumar, G | 1 |
| Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L | 1 |
| Angeletti, S; Ciotti, M; Dolfa, C; Favalli, C; Sakarikou, C | 1 |
| Alouache, S; Arlet, G; Bakour, R; Benhassine, T; Gautier, V; Iabadene, H; Messai, Y; Tazir, M | 1 |
| Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P | 1 |
| Berta, J; Damjanova, I; Füzi, M; Hajbel-Vékony, G; Jakab, M; Milch, H; Pászti, J; Tóth, A | 1 |
| Ikonomidis, A; Kristo, I; Markou, F; Poulou, A; Pournaras, S; Tsakris, A | 1 |
| Chen, Y; Cheng, J; Li, JB; Wang, Q; Ye, Y; Zhang, XJ | 1 |
| Brudney, D; Kaufmann, ME; Livermore, DM; Macdonald, A; Matos, J; Navon-Venezia, S; Sompolinsky, D; Warner, M; Woodford, N; Zhang, J | 1 |
| Asensi, MD; Guerra, LR; Peirano, G; Pinto, MC; Seki, LM; Val Passos, VL | 1 |
| Chan, J; Leo, YS; Lye, DC; Teng, CP; Wijaya, L | 1 |
| Ensor, VM; Evans, JT; Hawkey, PM; Jamal, W; Rotimi, VO | 1 |
| Carmeli, Y; Chmelnitsky, I; Colodner, R; Leavitt, A; Navon-Venezia, S; Ofek, I | 1 |
| Chen, HM; Tsai, PF; Wann, JY; Wu, JJ; Yan, JJ | 1 |
| Shah, PM | 1 |
| Koike, K; Kumita, W; Moriya, K; Ode, T; Okamura, N; Okugawa, S; Saito, R; Sato, K | 1 |
| Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Johnson, JL | 1 |
| Muniandy, S; Navaratnam, P; Palasubramaniam, S | 1 |
| Belhadj, O; Ben Achour, N; Ben Moussa, M; Galleni, M; Mercuri, PS | 1 |
| Bonomo, RA; Casiano-Colón, AE; Depasquale, JM; Endimiani, A; Fiorella, PD; Forero, S; Hujer, AM; Kitchel, B; Perez, F; Pickens, N; Roberts-Pollack, D; Tenover, FC | 1 |
| Bindayna, KM; Botta, GA; Khanfar, HS; Senok, AC | 1 |
| Blot, S; Memon, JI | 1 |
| Aligholi, M; Delfani, S; Feizabadi, MM; Majnooni, A; Parvin, M; Raji, N; Shahcheraghi, F; Yadegarinia, D | 1 |
| Carvalhaes, CG; Gales, AC; Nicoletti, AG; Picão, RC; Xavier, DE | 1 |
| Calvert, K; Clark, J; Hayden, MK; Lolans, K; Won, S | 1 |
| Bethel, C; Bonomo, RA; Choudhary, Y; Endimiani, A | 1 |
| Aihara, Y; Harada, T; Ito, S; Machida, H; Teranishi, J; Yokota, S | 1 |
| Hwang, KP; Shen, YH; Tang, YF | 1 |
| Cornaglia, G; Damjanova, I; Jánvári, L; Kocsis, B; Koncan, R; Konkoly-Thege, M; Kristóf, K; Nagy, K; Szabó, D; Szego, E; Tóth, A | 1 |
| Hao, F; Ma, N; Wang, H; Wei, X; Wen, Z; Xiao, Y; Xue, F; Zhu, Y | 1 |
| Carmeli, Y; Chmelnitsky, I; Goren, MG; Navon-Venezia, S; Schechner, V; Schwaber, MJ | 1 |
| Aschbacher, R; Carattoli, A; Larcher, C; Livermore, DM; March, A; Woodford, N | 1 |
| Berthelsen, BG; Fjeldsøe-Nielsen, H; Hasman, H; Lausten, T | 1 |
| Dogra, V; Loomba, P; Mishra, B; Taneja, J; Thakur, A | 1 |
| Chang, CM; Chen, PL; Ko, NY; Ko, WC; Lee, CC; Lee, HC; Lee, NY; Shih, HI; Wang, LR; Wu, CJ; Yan, JJ | 1 |
| Auncharoen, A; Chanawong, A; Kaewkes, W; Lulitanond, A; Pienthaweechai, K; Singtohin, S; Songsri, J; Sribenjalux, P | 1 |
| Arpin, C; Coulange, L; Dubois, V; Dutilh, B; Duvernay, C; Quentin, C | 1 |
| Li, JN; Li, XT; Tian, GB; Wang, HN; Wei, K; Xu, CW; Yang, ZR; Zeng, B; Zhang, AY; Zhou, YS; Zou, LK | 1 |
| Cai, J; Liu, J; Wu, D | 1 |
| Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C | 1 |
| Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F | 1 |
| Nordmann, P; Poirel, L; Toleman, MA; Walsh, TR | 1 |
| Chung, KP; Hsueh, PR; Huang, YT; Teng, LJ; Tsai, TH; Tseng, SP | 1 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC | 1 |
| Raghunathan, A; Samuel, L; Tibbetts, RJ | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Woosley, LN | 1 |
| Bencardino, A; Carattoli, A; Falcone, M; García-Fernández, A; Gianfreda, R; Giordano, A; Orsi, GB; Venditti, C; Venditti, M | 1 |
| Christidou, A; Gikas, A; Kritsotakis, EI; Roumbelaki, M; Tsioutis, C | 1 |
| Hammami, A; Ktari, S; Louati, F; Mahjoubi, F; Mezghani, S; Mnif, B; Rekik, S | 1 |
| Iyer, S; Maharjan, S; Perry, C; Pike, R; Stacey, A; Virgincar, N; Woodford, N; Wyeth, J | 1 |
| Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C; Livermore, DM; Woodford, N | 1 |
| Amyes, SG; Dancer, SJ; Findlay, J; Hamouda, A | 1 |
| Adams-Haduch, JM; Bogdanovich, T; Doi, Y; Kwak, EJ; Muto, CA; Nguyen, MH; Tian, GB | 1 |
| Giakkoupi, P; Papagiannitsis, CC; Pappa, O; Polemis, M; Tryfinopoulou, K; Tzelepi, E; Tzouvelekis, LS; Vatopoulos, AC | 1 |
| Chevet, K; Couzigou, C; Guyot, K; Janot, K; Lambert, T; Mellon, G; Misset, B; Nguyen Van, JC; Vidal, B | 1 |
| Chang, HJ; Chia, JH; Kuo, AJ; Lee, MH; Liu, SW; Wu, TL | 1 |
| An, D; Chong, Y; Chung, HS; Kim, MN; Lee, K; Woo, JH; Yong, D | 1 |
| Abreu-Lanfranco, O; Bhargava, P; Bheemreddy, S; Blunden, C; Carmeli, Y; Chopra, T; Chugh, N; Collins, VL; Eiseler, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Memon, BI; Moshos, J; Munoz-Price, LS; Pogue, JM; Shallal, A; Sunkara, B | 1 |
| Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
| Briales, A; de Alba, PD; Martínez-Martínez, L; Pascual, A; Rodríguez-Baño, J; Rodríguez-Martínez, JM; Velasco, C | 1 |
| Dimou, V; Iosifidis, E; Miyakis, S; Protonotariou, E; Roilides, E; Sianou, E; Sofianou, D; Zagorianou, A | 1 |
| Fong, JJ; Radigan, EA; Rosé, L | 1 |
| Cuzon, G; Demachy, MC; Naas, T; Nordmann, P | 2 |
| Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC | 1 |
| Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G | 1 |
| An, S; Chen, J; Chen, Y; Gao, Z; Li, J; Wang, H; Wang, Q; Wang, X; Wang, Z; Xu, X; Yan, X; Yang, J | 1 |
| Aumeran, C; Forestier, C; Hennequin, C; Robin, F; Traore, O | 1 |
| Huang, J; Li, G; Li, X; Zhu, N | 1 |
| Boyle, F; Boyle, L; Brisse, S; Burns, K; Condon, I; Cormican, M; Delannoy-Vieillard, AS; Finnegan, C; Humphreys, H; Khan, A; Monahan, R; Morris, C; Morris, D; Morris-Downes, M; O'Connell, N; O'Gorman, A; Powell, J; Power, L; Turton, J; Woodford, N | 1 |
| Adler, A; Aronov, R; Carmeli, Y; Edgar, R; Glick, J; Paikin, S; Schwaber, MJ; Sterlin, Y | 1 |
| Dong, Y; Li, H; Li, X; Sheng, H; Xiao, H; Yan, J; Yang, S; Zeng, X | 1 |
| Di Conza, J; Ghiglione, B; Gutkind, G; Pallecchi, L; Pino, M; Radice, M; Rossolini, GM; Santella, G; Sennati, S | 1 |
| Boisseau, D; Ferry-Blanco, C; Forestier, E; Gros, S; Labe, A; Lecomte, C; Levast, M; Peynaud, D; Rogeaux, O | 1 |
| Cherkaoui, A; Nordmann, P; Poirel, L; Potron, A; Renzi, G; Schrenzel, J | 1 |
| Arlet, G; Brisse, S; Decré, D; Drieux, L; Frangeul, L; Jarlier, V; Kassis-Chikhani, N; Sengelin, C | 1 |
| Eller, C; Pfeifer, Y | 1 |
| Nordmann, P; Poirel, L; Potron, A | 1 |
| Bonnin, RA; Carattoli, A; Nordmann, P; Poirel, L | 1 |
| Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D | 1 |
| de la Peña, S; Fernández-Soria, VM; Gómez-Gil, R; Gomez-Puertas, P; López-Camacho, E; Lusa-Bernal, S; Mingorance, J; Ramos-Ruiz, R; Ruiz-Carrascoso, G; Wesselink, JJ | 1 |
| Andreazzi, D; Caiaffa-Junior, HH; Cury, AP; Maffucci, M; Rossi, F | 1 |
| Collignon, P; Kennedy, K; Paterson, DL; Sidjabat, HE; Silvey, A | 1 |
| Chuang, CL; Jung, YC; Ko, WC; Wu, JJ; Yan, JJ | 1 |
| Elisha, BG; Nelson, EC; Segal, H | 1 |
| Baraniak, A; Gniadkowski, M; Jutersek, B; Sadowy, E; Storman, A; Zohar-Cretnik, T | 1 |
| Essack, SY; Hall, LM; Livermore, DM | 1 |
| Arakawa, Y; Doi, Y; Ito, H; Kubota, T; Shibata, N; Wachino, J; Yagi, T; Yamane, K | 1 |
| Bae, IK; Jeong, BC; Jeong, SH; Jung, HI; Kim, SJ; Kwon, SB; Lee, JH; Lee, SH; Song, JS | 1 |
| Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J | 1 |
| Babalola, C; Banevicius, MA; Maglio, D; Nicolau, DP; Nightingale, CH; Sutherland, C | 1 |
| Brízio, A; Conceição, T; Cristino, JM; Duarte, A; Lito, LM; Salgado, MJ | 1 |
| Del Carmen Rodríguez, M; Ramírez-Ronda, CH; Saavedra, S; Vera, DE | 1 |
| de Morais Júnior, MA; de Souza Lopes, AC; Falcão Rodrigues, J | 1 |
| Cano, ME; Conejo, MC; Martínez-Martínez, L; Pascual, A; Rodríguez-Martinez, JM; Velasco, C | 1 |
| Brink, AJ; Elliott, E; Els, Z; Livermore, DM; Turton, J; van Greune, J; Warner, M; Woodford, N | 1 |
| Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL | 1 |
| Bae, IK; Chang, CL; Hong, SG; Hwang, HY; Jeong, SH; Kim, HJ; Kwak, HS; Lee, BH; Youn, H | 1 |
| Caroff, N; Corvec, S; Cosano, D; Dauvergne, S; Drugeon, H; Reynaud, A | 1 |
| Dahl, KH; Haldorsen, B; Simonsen, GS; Steinbakk, M; Sundsfjord, A; Tofteland, S; Walsh, TR | 1 |
| DeRyke, CA; Nicolau, DP | 1 |
| Banevicius, MA; DeRyke, CA; Fan, HW; Nicolau, DP | 1 |
| DeRyke, CA; Kuti, JL; Nicolau, DP | 1 |
| Bae, IK; Hong, SG; Jeong, SH; Kim, HJ; Lee, JH; Lee, SH; Lee, YN; Youn, H | 1 |
| Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM | 1 |
| Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH | 1 |
| Bishara, J; Lishtzinsky, Y; Madar-Shapiro, L; Ofir, O; Samra, Z | 1 |
| Yoshida, A | 1 |
| Ko, CS; Koo, SH; Kwon, GC; Park, JW; Shin, SY; Sung, JY | 1 |
| Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV | 1 |
| Gülmez, D; Hascelik, G; Kocagoz, S; Livermore, DM; Metan, G; Mushtaq, S; Palepou, MF; Uzun, O; Woodford, N; Yakupogullari, Y | 1 |
| Chen, Y; Deng, L; Deng, Q; Ding, H; Liu, L; Lu, Q; Shen, X; Wang, A; Wang, C; Wang, L; Wang, Y; Xu, X; Yang, Y; Zhang, H | 1 |
| Bakkouch, A; Duault, M; Dupeyron, C; Leluan, G; Louarn, F; Mangeney, N; Niel, P; Pons, JL; Royan, F | 1 |
| Bailey, TC; Jett, BD; Reichley, R; Ritchie, DJ; Sahm, DF | 1 |
| Arlet, G; Lagrange, PH; Marchese, A; Philippon, A; Schito, GC | 1 |
| Kazmierczak, A; Lopez, J; Neuwirth, C; Pechinot, A; Siebor, E | 1 |
| French, GL; Shannon, KP; Simmons, N | 1 |
| Biddle, JW; Culver, DH; Edwards, JR; Gaynes, RP; Martone, WJ; Monnet, DL; Tenover, FC; Tolson, JS | 1 |
| Ardanuy, C; Ariza, J; Gudiol, F; Liñares, J; Pallares, R; Peña, C; Pujol, M; Ricart, A | 1 |
| Chang, SC; Ho, M; Hsueh, PR; Lee, CY; Lin, FM; Lu, PL; Luh, KT; Siu, LK | 1 |
| Karim, A; Le Thomas, I; Naas, T; Nordmann, P; Poirel, L | 1 |
| Hall, LM; Livermore, DM; Savelkoul, PH; Vandenbroucke-Grauls, CM; Yuan, M | 1 |
| Amyes, SG; Gulay, Z; Thomson, CJ; Yulug, N | 1 |
| Fey, PD; Langnas, AN; Olsen, KM; Rebuck, JA; Rupp, ME | 1 |
| Blahova, J; Croco, MA; Eidelstain, MV; Hollis, RJ; Jones, RN; Pfaller, MA; Reshedko, GK; Stetsiouk, O; Stratchounski, L; Winokur, PL | 1 |
| Rice, L | 1 |
| Jeong, SH; Lee, KJ; Lee, SH | 1 |
| Aihara, M; Ikeda, N; Kinoshita, S; Komatsu, M; Nakamachi, Y; Shimakawa, K; Yamasaki, K | 1 |
| Inoue, M | 1 |
| Jones, RN; Shen, D; Winokur, P | 1 |
| Aguilar, C; Becerra, Z; Echániz, G; Garza-Ramos, U; Gatica, R; Leaños, B; Miranda, G; Silva, J; Solórzano, F; Velázquez, M | 1 |
| Mansa, B; Nir, M; Schumacher, H; Thomsen, VF | 1 |
| Arlet, G; Fournier, G; Marie, O; Philippon, A; Rouveau, M; Sanson-le Pors, MJ; Schlemmer, B | 1 |
| Cox, DM; Plested, SJ; Spencer, RC; Wheat, PF; Winstanley, TG | 1 |
| Brückner, O; Hahn, H; Marre, R; Trautmann, M | 1 |
| Nishino, T; Obana, Y; Tanino, T | 1 |
3 review(s) available for beta-lactams and Infections, Klebsiella
| Article | Year |
|---|---|
The Spread of CTX-M-Type Extended-Spectrum β-Lactamases in Brazil: A Systematic Review.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Brazil; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Expression; Gene Transfer, Horizontal; Hospitals; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology | 2016 |
Correlation between antimicrobial resistance and virulence in Klebsiella pneumoniae.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporinase; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression; Genome-Wide Association Study; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Virulence | 2016 |
[Attention-getting cross infections: Extended-spectrum beta-lactamase-producing bacterial infections].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Proteus; Proteus Infections | 2007 |
1 trial(s) available for beta-lactams and Infections, Klebsiella
| Article | Year |
|---|---|
Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Drug Resistance, Multiple; Ertapenem; Female; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Statistics, Nonparametric | 2017 |
213 other study(ies) available for beta-lactams and Infections, Klebsiella
| Article | Year |
|---|---|
High Osmotic Stress Increases OmpK36 Expression through the Regulation of KbvR to Decrease the Antimicrobial Resistance of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Osmotic Pressure; Porins | 2022 |
Genomic characterization of BKC-1-producing Klebsiella pneumoniae strain belonging to high-risk clone sequence type 11 isolated from a river in Brazil.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Carbapenems; Clone Cells; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genomics; Humans; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymyxins; Rivers; Siderophores; Type VI Secretion Systems | 2022 |
An outbreak of extensively drug-resistant and hypervirulent
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; China; Colistin; Disease Outbreaks; Hospitals, Teaching; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Quinolones; Tigecycline; Virulence; Virulence Factors | 2022 |
Genomic analysis of a pan-resistant Klebsiella pneumoniae sequence type 11 identified in Japan in 2016.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Whole Genome Sequencing | 2020 |
Genomic characterization of Inc
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Female; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Replicon | 2020 |
Fluoroquinolones as an alternative treatment for Klebsiella pneumoniae liver abscess and impact on hospital length of stay.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Female; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Liver Abscess; Male; Middle Aged; Retrospective Studies; Taiwan; Treatment Outcome | 2020 |
Hypermucoviscous/hypervirulent and extensively drug-resistant QnrB2-, QnrS1-, and CTX-M-3-coproducing Klebsiella pneumoniae ST2121 isolated from an infected elephant (Loxodonta africana).
Topics: Animals; Animals, Zoo; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Brazil; Drug Resistance, Multiple, Bacterial; Elephants; Escherichia coli; Klebsiella Infections; Klebsiella pneumoniae; Larva; Microbial Sensitivity Tests; Moths; Multilocus Sequence Typing; Plasmids; Quinolones; Virulence | 2020 |
β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutation; Porins | 2021 |
The Carbapenemase BKC-1 from Klebsiella pneumoniae Is Adapted for Translocation by Both the Tat and Sec Translocons.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Biological Transport; Escherichia coli; Gene Products, tat; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Periplasm; SEC Translocation Channels | 2021 |
Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Cyclooctanes; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2021 |
Difficult Cases of Odontogenic Deep Neck Infections: A Report of Three Patients.
Topics: Adult; Ampicillin; beta-Lactams; Clindamycin; Drainage; Ertapenem; Focal Infection, Dental; Gentamicins; Humans; Infections; Klebsiella Infections; Male; Middle Aged; Neck; Periodontal Abscess; Streptococcal Infections; Sulbactam | 2017 |
First Case of NDM-1-Producing Klebsiella pneumoniae in Annaba University Hospital, Algeria.
Topics: Adult; Algeria; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clone Cells; Drug Resistance, Multiple, Bacterial; Ertapenem; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids | 2017 |
Every cloud has a silver lining.
Topics: Anti-Bacterial Agents; beta-Lactams; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Thienamycins | 2017 |
Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population.
Topics: Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Catheter-Related Infections; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Neutropenia; Propensity Score; Urinary Tract Infections | 2017 |
Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; beta-Lactams; Drug Combinations; Ertapenem; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Sarcoma, Myeloid; Sepsis; Thienamycins; Transplantation, Homologous; Treatment Outcome | 2018 |
Cost of Nosocomial Outbreak Caused by NDM-1-Containing Klebsiella pneumoniae in the Netherlands, October 2015-January 2016.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carrier State; Cost of Illness; Cross Infection; Disease Outbreaks; Gene Expression; Hospitals; Humans; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Netherlands; Plasmids | 2017 |
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2017 |
Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Porins | 2018 |
Impact of OqxR loss of function on the envelope proteome of Klebsiella pneumoniae and susceptibility to antimicrobials.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Chromatography, Liquid; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Loss of Function Mutation; Membrane Transport Proteins; Microbial Sensitivity Tests; Porins; Proteome; Tandem Mass Spectrometry | 2018 |
Comparison of adhesin genes expression among Klebsiella oxytoca ESBL-non-producers in planktonic and biofilm mode of growth, and imipenem sublethal exposure.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biofilms; Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Phenotype | 2019 |
Changing epidemiology of KPC-producing Klebsiella pneumoniae in Argentina: Emergence of hypermucoviscous ST25 and high-risk clone ST307.
Topics: Argentina; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Plasmids | 2019 |
Synergistic Combinations and Repurposed Antibiotics Active against the Pandrug-Resistant Klebsiella pneumoniae Nevada Strain.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colistin; Drug Combinations; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fusidic Acid; Gene Expression; Glycopeptides; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lincosamides; Macrolides; Microbial Sensitivity Tests | 2019 |
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections | 2013 |
Hierarchical clustering as a rapid tool for surveillance of emerging antibiotic-resistance phenotypes in Klebsiella pneumoniae strains.
Topics: Algeria; Algorithms; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Cluster Analysis; Computational Biology; Drug Resistance, Bacterial; France; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Population Surveillance; Prevalence; Software | 2013 |
Efficacy of doripenem and ertapenem against KPC-2-producing and non-KPC-producing Klebsiella pneumoniae with similar MICs.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Ertapenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Treatment Outcome | 2013 |
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome | 2013 |
Class 1 integrons in urinary isolates of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Southern China during the past five years.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Integrases; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multigene Family; Phylogeny; Polymerase Chain Reaction; Sequence Analysis, DNA | 2013 |
Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Comorbidity; Cross Infection; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2013 |
In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other β-lactams.
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Combinations; Drug Resistance, Bacterial; Edetic Acid; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Sulbactam | 2013 |
OXA-48-like carbapenemase-producing Enterobacteriaceae in Ottawa, Canada.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Ontario; Plasmids; Young Adult | 2013 |
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; beta-Lactams; Carbapenems; Disease Models, Animal; Doripenem; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Time Factors | 2013 |
Outbreak caused by an ertapenem-resistant, CTX-M-15-producing Klebsiella pneumoniae sequence type 101 clone carrying an OmpK36 porin variant.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cluster Analysis; Disease Outbreaks; DNA, Bacterial; Ertapenem; Female; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Porins; Young Adult | 2013 |
Detection of VIM-34, a novel VIM-1 variant identified in the intercontinental ST15 Klebsiella pneumoniae clone.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2014 |
Large oligoclonal outbreak due to Klebsiella pneumoniae ST14 and ST26 producing the FOX-7 AmpC β-lactamase in a neonatal intensive care unit.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Typing | 2013 |
Characteristics of community-onset NDM-1-producing Klebsiella pneumoniae isolates.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Conjugation, Genetic; Gene Order; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Male; Molecular Typing; Plasmids | 2014 |
An outbreak of a nosocomial NDM-1-producing Klebsiella pneumoniae ST147 at a teaching hospital in mainland China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Hospitals, Teaching; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Plasmids | 2014 |
Detection and molecular characterization of Escherichia coli CTX-M-15 and Klebsiella pneumoniae SHV-12 β-lactamases from bovine mastitis isolates in the United Kingdom.
Topics: Animals; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cattle; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Plasmids; United Kingdom | 2014 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index | 2014 |
Rapid ertapenem susceptibility testing and Klebsiella pneumoniae carbapenemase phenotype detection in Klebsiella pneumoniae isolates by use of automated microscopy of immobilized live bacterial cells.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microscopy; Phenotype | 2014 |
KPC-3 carbapenemase harbored in FIIk plasmid from Klebsiella pneumoniae ST512 and Escherichia coli ST43 in the same patient.
Topics: Abdominal Abscess; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Bile; Colistin; Conjugation, Genetic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterobacter aerogenes; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Gene Expression; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Plasmids; Tigecycline | 2014 |
High prevalence of Klebsiella pneumoniae carbapenemase-mediated resistance in K. pneumoniae isolates from Egypt.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Egypt; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Prospective Studies | 2013 |
Novel NDM-9 metallo-β-lactamase identified from a ST107 Klebsiella pneumoniae strain isolated in China.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; China; Gene Expression; Humans; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2014 |
[Risk factors associated with the isolation of extended spectrum betalactamases producing Escherichia coli or Klebsiella pneumoniae in a tertiary care hospital in Colombia].
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Colombia; Cross Infection; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Tertiary Care Centers | 2014 |
Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cephalosporins; Cross Infection; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2014 |
ESBL-producing Escherichia coli and Klebsiella pneumoniae at a tertiary care hospital in Saudi Arabia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Saudi Arabia; Tertiary Care Centers; Young Adult | 2014 |
Evaluation of inhibitory action of novel non β-lactam inhibitor against Klebsiella pneumoniae carbapenemase (KPC-2).
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Cell Line; Ertapenem; HeLa Cells; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Protein Binding; Thienamycins | 2014 |
Comparison of multilocus sequence typing, RAPD, and MALDI-TOF mass spectrometry for typing of β-lactam-resistant Klebsiella pneumoniae strains.
Topics: Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Random Amplified Polymorphic DNA Technique; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Coproduction of NDM-1 and KPC-2 in Enterobacter hormaechei from Brazil.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacter; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Plasmids; Polymyxin B | 2015 |
First case of NDM-1 producing Klebsiella pneumoniae in Caribbean islands.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cuba; Guadeloupe; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Travel | 2015 |
Mechanism of resistance and antibacterial susceptibility in extended-spectrum β-lactamase phenotype Klebsiella pneumoniae and Klebsiella oxytoca isolated between 2000 and 2010 in Japan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2015 |
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds | 2015 |
Antibiofilm peptides increase the susceptibility of carbapenemase-producing Klebsiella pneumoniae clinical isolates to β-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Biofilms; Culture Media; Drug Resistance, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Peptides | 2015 |
Characterization of extended-spectrum beta-lactamases and antimicrobial resistance of Klebsiella pneumoniae in intra-abdominal infection isolates in Latin America, 2008-2012. Results of the Study for Monitoring Antimicrobial Resistance Trends.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Humans; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Latin America | 2015 |
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs | 2015 |
Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cattle; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Feces; Female; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Polymerase Chain Reaction | 2015 |
Bactericidal and synergistic activity of double-carbapenem regimen for infections caused by carbapenemase-producing Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Sepsis; Thienamycins | 2016 |
Successful international clones of blaCTX-M-15-producing Klebsiella pneumoniae with coexpression of plasmid-mediated quinolone resistance (PMQR) determinants in Tehran hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Typing; Plasmids; Quinolones | 2015 |
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult | 2015 |
Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Japan; Klebsiella Infections; Klebsiella oxytoca; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Penicillanic Acid; Piperacillin; Tazobactam | 2015 |
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Ertapenem; Female; Humans; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Survival Analysis; Treatment Outcome; Urinary Tract Infections | 2016 |
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Electroencephalography; Electromyography; Enterococcus faecalis; Ertapenem; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Renal Insufficiency, Chronic; Risk Factors; Urinary Tract Infections | 2015 |
Update on monitoring the spread of KPC carbapenemase-producing Klebsiella spp. in South Brazil.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Brazil; Epidemiological Monitoring; Female; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged | 2016 |
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine | 2016 |
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure | 2016 |
[TEM and CTX-M extended-spectrum beta-lactamase in Klebsiella spp and Escherichia coli isolates from inanimate surfaces of hospital environments].
Topics: beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2015 |
Use of whole-genome sequencing to trace, control and characterize the regional expansion of extended-spectrum β-lactamase producing ST15 Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Cross Infection; Disease Outbreaks; Gene Expression; High-Throughput Nucleotide Sequencing; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multiplex Polymerase Chain Reaction; Netherlands; Patient Identification Systems; Public Health Surveillance; Virulence | 2016 |
Colistin Increases the Cidal Activity of Antibiotic Combinations Against Multidrug-Resistant Klebsiella pneumoniae: An In Vitro Model Comparing Multiple Combination Bactericidal Testing at One Peak Serum Concentration and Time-Kill Method.
Topics: Anti-Bacterial Agents; beta-Lactams; Colistin; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Minocycline; Predictive Value of Tests; Rifampin; Thienamycins; Tigecycline | 2016 |
Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae.
Topics: Australia; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Phenotype | 2016 |
A case of hypermucoviscous Klebsiella pneumoniae liver abscess syndrome in an Iraqi male.
Topics: Administration, Intravenous; Anti-Bacterial Agents; beta-Lactams; Communicable Diseases, Emerging; Decompression, Surgical; Drainage; Ertapenem; Humans; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Microbial Sensitivity Tests; Middle Aged; Syndrome; Treatment Outcome | 2016 |
Fecal Carriage of Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamases in Hospitalized Patients and Healthy Community Volunteers in Burkina Faso.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Burkina Faso; Case-Control Studies; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Fluoroquinolones; Gene Expression; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Multiplex Polymerase Chain Reaction; Phylogeny | 2017 |
High Prevalence of Plasmid-Mediated Quinolone Resistance Determinants in Escherichia coli and Klebsiella pneumoniae Isolates from Pediatric Patients in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; China; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Public Health Surveillance; Quinolones; Sequence Analysis, DNA | 2017 |
In vitro potency of amikacin and comparators against E. coli, K. pneumoniae and P. aeruginosa respiratory and blood isolates.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2016 |
Molecular characterisation of Klebsiella oxytoca strains isolated from patients with antibiotic-associated diarrhoea.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Colitis; Cytotoxins; Diarrhea; Disk Diffusion Antimicrobial Tests; Feces; Female; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Male; Middle Aged; Young Adult | 2016 |
Outbreak of OXA-48-Producing Klebsiella pneumoniae Involving a Sequence Type 101 Clone in Batna University Hospital, Algeria.
Topics: Algeria; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Clone Cells; Conjugation, Genetic; Disease Outbreaks; Ertapenem; Gene Expression; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Nephritis; Phylogeny; Plasmids | 2016 |
Morphological changes induced by β-lactam antibiotics observed on Gram staining.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ertapenem; Gentian Violet; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Osteomyelitis; Phenazines | 2017 |
IncFIIk plasmid harbouring an amplification of 16S rRNA methyltransferase-encoding gene rmtH associated with mobile element ISCR2.
Topics: Aminoglycosides; beta-Lactams; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Gene Transfer, Horizontal; Humans; Infant, Newborn; Interspersed Repetitive Sequences; Klebsiella Infections; Klebsiella pneumoniae; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2017 |
Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Chloramphenicol; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Gene Expression; Hospitals, University; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Retrospective Studies; Survival Analysis; Tigecycline; Tunisia | 2017 |
Molecular and in silico analysis of a new plasmid-mediated AmpC β-lactamase (CMH-2) in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Catalytic Domain; Computer Simulation; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular | 2017 |
E152A substitution drastically affects NDM-5 activity.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenems; Catalytic Domain; Drug Resistance, Multiple, Bacterial; Escherichia coli; Glutamic Acid; Hydrolysis; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mutation | 2017 |
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States | 2017 |
Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS).
Topics: Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Blood Culture; Cell Culture Techniques; Cross Infection; Enterobacteriaceae; Ertapenem; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Laboratories; Proteomics; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2017 |
Prevalence and characterization of extended-spectrum beta-lactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria).
Topics: Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Polymerase Chain Reaction; Prevalence; Substrate Specificity | 2008 |
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2008 |
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxacin; Cluster Analysis; Conjugation, Genetic; Cross Infection; Disease Outbreaks; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Hungary; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Plasmids; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Sequence Analysis, DNA | 2008 |
First occurrence of KPC-2-possessing Klebsiella pneumoniae in a Greek hospital and recommendation for detection with boronic acid disc tests.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Boronic Acids; Conjugation, Genetic; Female; Genes, Bacterial; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction | 2008 |
ACT-3, a novel plasmid-encoded class C beta-lactamase in a Klebsiella pneumoniae isolate from China.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; China; Conjugation, Genetic; Escherichia coli; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2009 |
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cluster Analysis; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Female; Genes, Bacterial; Genotype; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; United Kingdom | 2008 |
Carbapenem-hydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Brazil; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Ertapenem for treatment of extended-spectrum beta-lactamase-producing and multidrug-resistant gram-negative bacteraemia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Urinary Tract Infections | 2008 |
Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Kuwait | 2009 |
Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Polyacrylamide Gel; Ertapenem; Genotype; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2009 |
Evaluation of the capability of the VITEK 2 system to detect extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates, in particular with the coproduction of AmpC enzymes.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sensitivity and Specificity | 2009 |
Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Germany; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2009 |
Analysis of plasmid-mediated multidrug resistance in Escherichia coli and Klebsiella oxytoca isolates from clinical specimens in Japan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Integrons; Japan; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Plasmids; Quinolones; Sequence Analysis, DNA | 2009 |
Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Colombia; Drug Resistance, Bacterial; Greece; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Population Surveillance; Puerto Rico; Tigecycline | 2009 |
Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Western; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Nucleic Acid Hybridization; Plasmids; Porins; Sequence Analysis, DNA | 2009 |
Characterization of a novel extended-spectrum TEM-type beta-lactamase, TEM-164, in a clinical strain of Klebsiella pneumoniae in Tunisia.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Tunisia | 2009 |
Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Florida; Hospitals; Humans; Immunoblotting; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Community-Acquired Infections; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2009 |
Risk factors and outcome in extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 2009 |
Distribution of bla(TEM), bla(SHV), bla(CTX-M) genes among clinical isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, Iran.
Topics: Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Genes, Bacterial; Hospitals, Teaching; Humans; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2010 |
Cloverleaf test (modified Hodge test) for detecting carbapenemase production in Klebsiella pneumoniae: be aware of false positive results.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; False Positive Reactions; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Porins | 2010 |
Direct ertapenem disk screening method for identification of KPC-producing Klebsiella pneumoniae and Escherichia coli in surveillance swab specimens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier State; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mass Screening; Microbial Sensitivity Tests; Rectum; Sensitivity and Specificity | 2010 |
In vitro activity of penem-1 in combination with beta-lactams against blaKPC-possessing Klebsiella pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Enzyme Inhibitors; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2010 |
Extended-spectrum beta-lactamase-producing bacteria and vesicoureteral reflux in children.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli Infections; Humans; Infant; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Male; Pyelonephritis; Recurrence; Urinary Tract Infections; Vesico-Ureteral Reflux | 2010 |
Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Community-Acquired Infections; Drug Resistance, Bacterial; Escherichia coli Infections; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Taiwan | 2009 |
Identification of a blaVIM-4 gene in the internationally successful Klebsiella pneumoniae ST11 clone and in a Klebsiella oxytoca strain in Hungary.
Topics: beta-Lactamases; beta-Lactams; DNA, Bacterial; Humans; Hungary; Integrons; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Sequence Analysis, DNA | 2010 |
Intervention study of the association of antibiotic utilization measures with control of extended-spectrum beta-lactamase (ESBL)-producing bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Rectum | 2010 |
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Conjugation, Genetic; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Escherichia coli; Escherichia coli Infections; Gastrointestinal Tract; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Male; Metronidazole; Plasmids; Vancomycin | 2010 |
Complete nucleotide sequence of the IncN plasmid pKOX105 encoding VIM-1, QnrS1 and SHV-12 proteins in Enterobacteriaceae from Bolzano, Italy compared with IncN plasmids encoding KPC enzymes in the USA.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Chromosome Walking; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Italy; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Long-Term Care; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA; United States | 2010 |
Isolation of a VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae isolate in Denmark.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Denmark; DNA, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2010 |
Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tetracycline | 2010 |
Salvage therapy with tigecycline for recurrent infection caused by ertapenem-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Diabetes Complications; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Minocycline; Osteomyelitis; Pyomyositis; Recurrence; Salvage Therapy; Tigecycline; Treatment Outcome | 2010 |
CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC β-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Thailand | 2010 |
Duplication of the chromosomal blaSHV-11 gene in a clinical hypermutable strain of Klebsiella pneumoniae.
Topics: Aged, 80 and over; beta-Lactamases; beta-Lactams; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gene Duplication; Genetic Complementation Test; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; MutS DNA Mismatch-Binding Protein; Phenotype; Sequence Analysis, DNA; Virulence | 2011 |
Phenotypic and genotypic characterization of β-lactam resistance in Klebsiella pneumoniae isolated from swine.
Topics: Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing; Phenotype; Phylogeny; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Swine; Swine Diseases | 2011 |
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins | 2011 |
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States | 2011 |
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Communicable Diseases, Emerging; Disease Transmission, Infectious; Escherichia coli; Escherichia coli Infections; Humans; India; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Mass Screening; Pakistan; Pandemics; Sweden; United Kingdom | 2011 |
Arrival of Klebsiella pneumoniae carbapenemase (KPC)-2 in Taiwan.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Taiwan | 2011 |
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome | 2011 |
Evaluation of a real-time PCR assay for the detection of the Klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified Hodge test.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Ertapenem; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Predictive Value of Tests | 2011 |
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
Topics: Americas; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Europe; Humans; Incidence; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2011 |
Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactams; Cluster Analysis; Ertapenem; Female; Genotype; Hospitalization; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Porins; Risk Factors; Treatment Outcome | 2011 |
Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Case-Control Studies; Drug Utilization; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Assessment | 2011 |
Spread of Klebsiella pneumoniae isolates producing OXA-48 β-lactamase in a Tunisian university hospital.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Cross Infection; Gene Transfer, Horizontal; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tunisia | 2011 |
Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, General; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Typing; Polymerase Chain Reaction; Sequence Analysis, DNA; United Kingdom | 2011 |
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2011 |
Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactams; Catheter-Related Infections; Conjugation, Genetic; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Gene Expression Profiling; Gene Transfer, Horizontal; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Molecular Weight; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Thienamycins; Urinary Tract Infections; Urine | 2012 |
Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2011 |
Diversity of acquired β-lactamases amongst Klebsiella pneumoniae in Greek hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Greece; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Typing | 2012 |
[Phenotypic detection of carbapenemase associated with extended-spectrum beta-lactamase in Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Paris; Phenotype; Substrate Specificity | 2012 |
Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: a matched case-control study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactams; Case-Control Studies; Ertapenem; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome | 2012 |
Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cluster Analysis; Cross Infection; Disk Diffusion Antimicrobial Tests; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Multilocus Sequence Typing; Republic of Korea | 2012 |
Efficacy of ertapenem for treatment of bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2012 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
Prevalence of plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases in Spain.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Child, Preschool; Conjugation, Genetic; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Quinolones; Spain | 2012 |
Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Female; Gene Amplification; Genotype; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction; Prevalence; Sequence Analysis, DNA | 2012 |
Clinical outcomes with ertapenem as a first-line treatment option of infections caused by extended-spectrum β-lactamase producing gram-negative bacteria.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged | 2012 |
Nosocomial outbreak of Klebsiella pneumoniae harbouring bla(KPC-3) in France subsequent to a patient transfer from Italy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; France; Genotype; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Patient Transfer; Plasmids | 2012 |
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult | 2012 |
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2012 |
Predominant characteristics of CTX-M-producing Klebsiella pneumoniae isolates from patients with lower respiratory tract infection in multiple medical centers in China.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Respiratory Tract Infections; Sequence Analysis, DNA | 2012 |
Antibiotic resistance and plasmid transfer capacity in biofilm formed with a CTX-M-15-producing Klebsiella pneumoniae isolate.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Biofilms; Cross Infection; Disease Outbreaks; France; Gene Transfer, Horizontal; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2012 |
Genetic characteristics of one highly multi-drug-resistant strain of Klebsiella ozaenae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; China; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction; Quinolones; Sequence Analysis, DNA | 2012 |
Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland.
Topics: beta-Lactamases; beta-Lactams; Disease Outbreaks; Ertapenem; Genes, Bacterial; Hospitals; Humans; Imipenem; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Thienamycins | 2012 |
A swordless knight: epidemiology and molecular characteristics of the blaKPC-negative sequence type 258 Klebsiella pneumoniae clone.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Prospective Studies | 2012 |
Investigation of genetic diversity of the bla(SHV) gene and development of an oligonucleotide microarray to detect mutations in the bla(SHV) gene.
Topics: Alleles; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA Mutational Analysis; Genes, Bacterial; Genetic Variation; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mutation; Oligonucleotide Array Sequence Analysis | 2012 |
Changing epidemiology of extended-spectrum β-lactamases in Argentina: emergence of CTX-M-15.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Genetic Heterogeneity; Humans; Klebsiella Infections; Klebsiella pneumoniae | 2012 |
[Ertapenem administered intravenously or subcutaneously for urinary tract infections caused by ESBL producing enterobacteriacea].
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cystitis; Drug Evaluation; Ertapenem; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Humans; Injections, Intravenous; Injections, Subcutaneous; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prostatitis; Pyelonephritis; Recurrence; Retrospective Studies; Risk Factors | 2012 |
Emergence of OXA-48-producing Enterobacteriaceae in Switzerland.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; DNA Transposable Elements; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Switzerland | 2012 |
Complete nucleotide sequence of the first KPC-2- and SHV-12-encoding IncX plasmid, pKpS90, from Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disease Outbreaks; DNA Transposable Elements; France; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2013 |
[Current data and trends about the resistance of Gram-negative pathogens to beta-lactams].
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Europe; Germany; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Serotyping | 2012 |
Characterization of OXA-204, a carbapenem-hydrolyzing class D β-lactamase from Klebsiella pneumoniae.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Base Sequence; beta-Lactams; DNA Transposable Elements; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Substrate Specificity; Tunisia | 2013 |
Comparative genomics of IncL/M-type plasmids: evolution by acquisition of resistance genes and insertion sequences.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactams; Biological Evolution; DNA Transposable Elements; Genomics; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Plasmids; Sequence Analysis, DNA | 2013 |
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors | 2012 |
Genome sequence of OXA-48 carbapenemase-producing Klebsiella pneumoniae KpO3210.
Topics: Bacterial Proteins; beta-Lactamases; beta-Lactams; Blood; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2012 |
The modified Hodge test is a useful tool for ruling out Klebsiella pneumoniae carbapenemase.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Predictive Value of Tests | 2012 |
Emergence of bla(OXA-181)-carrying ColE plasmid in Klebsiella pneumoniae in Australia.
Topics: Aged; Anti-Bacterial Agents; Australia; beta-Lactamases; beta-Lactams; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids | 2013 |
Emergence of Klebsiella pneumoniae isolates producing inducible DHA-1 beta-lactamase in a university hospital in Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Conjugation, Genetic; Drug Resistance, Bacterial; Enzyme Induction; Female; Hospitals, University; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Ribotyping; Taiwan | 2002 |
Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Porins; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2003 |
Complex endemic situation regarding extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a hospital in Slovenia.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Conjugation, Genetic; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Hospitals; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Prevalence; Slovenia | 2003 |
Klebsiella pneumoniae isolate from South Africa with multiple TEM, SHV and AmpC beta-lactamases.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; South Africa | 2004 |
Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a beta-lactamase, GES-3, in a neonatal intensive care unit in Japan.
Topics: Amino Acid Sequence; beta-Lactamases; beta-Lactams; Blotting, Southern; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Infant, Newborn; Intensive Care, Neonatal; Isoelectric Focusing; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
Investigation of extended-spectrum beta-lactamases produced by clinical isolates of Klebsiella pneumoniae and Escherichia coli in Korea.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2004 |
Pharmacodynamic profile of ertapenem against Klebsiella pneumoniae and Escherichia coli in a murine thigh model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Colony Count, Microbial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Thigh | 2005 |
First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal.
Topics: beta-Lactamases; beta-Lactams; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Portugal | 2005 |
Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Escherichia coli; Escherichia coli Infections; Hospitals, Veterans; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Puerto Rico | 2004 |
Molecular typing of Klebsiella pneumoniae isolates from public hospitals in Recife, Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Brazil; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Hospitals, Public; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Random Amplified Polymorphic DNA Technique | 2005 |
Evaluation of antimicrobial susceptibility of bacteria containing the qnr gene and FOX-5 beta-lactamase by four automated systems.
Topics: Anti-Bacterial Agents; Automation; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Transfection | 2005 |
In vivo development of ertapenem resistance in a patient with pneumonia caused by Klebsiella pneumoniae with an extended-spectrum beta-lactamase.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2006 |
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome | 2006 |
A novel ceftazidime-hydrolysing extended-spectrum beta-lactamase, CTX-M-54, with a single amino acid substitution at position 167 in the omega loop.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Ceftazidime; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2006 |
Increased resistance to beta-lactams in a Klebsiella pneumoniae strain: role of a deletion downstream of the Pribnow box in the blaSHV-1 promoter.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Drug Resistance, Bacterial; Gene Deletion; Gene Expression Regulation, Bacterial; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Promoter Regions, Genetic | 2006 |
Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norway; Phenotype | 2007 |
Is all free time above the minimum inhibitory concentration the same: implications for beta-lactam in vivo modelling.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Models, Biological | 2007 |
Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
Topics: Animals; beta-Lactamases; beta-Lactams; Disease Models, Animal; Ertapenem; Escherichia coli; Escherichia coli Infections; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Mice; Microbial Sensitivity Tests; Thienamycins | 2007 |
Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactams; Cross Infection; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; Intensive Care Units; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; United States | 2007 |
Genetic and biochemical characterization of GES-5, an extended-spectrum class A beta-lactamase from Klebsiella pneumoniae.
Topics: beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cloning, Molecular; DNA, Bacterial; Female; Humans; Integrons; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Sputum | 2007 |
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel | 2007 |
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins | 2007 |
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Disease Outbreaks; Hospitals, University; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA | 2007 |
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids | 2008 |
[Prevalence of extended-spectrum beta-lactamases in Escherichia coli and Klebsiella pneumoniae from Daejeon].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Korea | 2007 |
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States | 2008 |
Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Bacterial; Turkey | 2008 |
The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children's hospitals in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; China; Conjugation, Genetic; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Hospitals, Pediatric; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2008 |
[Outbreak of infections of Klebsiella pneumoniae with extended spectrum beta-lactamase in a hospital unit with a long and medium stay].
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Case-Control Studies; Cross Infection; Disease Outbreaks; Electrophoresis, Polyacrylamide Gel; France; Hospital Units; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors | 1995 |
In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 1995 |
Detection of SHV-5 extended-spectrum beta-lactamase in Klebsiella pneumoniae strains isolated in Italy.
Topics: beta-Lactamases; beta-Lactams; Conjugation, Genetic; DNA Fingerprinting; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Humans; Isoelectric Focusing; Italy; Klebsiella Infections; Klebsiella pneumoniae; Plasmids | 1996 |
Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; France; Genotype; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction | 1996 |
Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporin Resistance; Child; Child, Preschool; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; London | 1996 |
Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System.
Topics: Anti-Bacterial Agents; beta-Lactams; Cross Infection; DNA, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Population Surveillance; Regression Analysis; United States | 1997 |
Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Risk Factors | 1998 |
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Conjugation, Genetic; DNA Fingerprinting; Escherichia coli; Escherichia coli Infections; Female; Genome, Bacterial; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Oncology Service, Hospital; Pediatrics; Plasmids; Polymerase Chain Reaction | 1999 |
Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Female; Humans; Infant, Newborn; Integrases; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2000 |
SHV-13, a novel extended-spectrum beta-lactamase, in Klebsiella pneumoniae isolates from patients in an intensive care unit in Amsterdam.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; DNA Fingerprinting; Intensive Care Units, Neonatal; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction | 2000 |
High prevalence of extended spectrum beta-lactamase production among Klebsiella pneumoniae strains isolated at a University Hospital in Turkey.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Turkey | 2000 |
Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
Topics: Adolescent; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Intensive Care Units, Pediatric; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Organ Transplantation; Risk Factors | 2000 |
Russian Klebsiella pneumoniae isolates that express extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Russia; Substrate Specificity | 2000 |
Evolution and clinical importance of extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2001 |
Evolution of TEM beta--lactamase genes identified by PCR with newly designed primers in Korean clinical isolates.
Topics: beta-Lactamases; beta-Lactams; DNA Primers; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Evolution, Molecular; Humans; Infant; Klebsiella Infections; Klebsiella pneumoniae; Korea; Polymerase Chain Reaction | 2001 |
Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Polymerase Chain Reaction | 2001 |
Hospital outbreak of MEN-1-derived extended spectrum beta-lactamase-producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Genotype; Humans; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction | 2001 |
Characterization of extended spectrum beta-lactamase-producing Klebsiella pneumoniae from Beijing, China.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; China; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Ribotyping | 2001 |
Outbreak of infection with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a Mexican hospital.
Topics: Bacteremia; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Mexico; Microbial Sensitivity Tests | 2001 |
Screening method for beta-lactamase substrate profiles.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Klebsiella; Klebsiella Infections; Methods; Pseudomonas; Reproducibility of Results; Substrate Specificity | 1992 |
Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Paris; R Factors; Respiratory System; Risk Factors; Sepsis; Surgical Wound Infection; Urinary Tract | 1990 |
Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male | 1987 |
Comparative efficacy of different beta-lactam antibiotics and gentamicin in Klebsiella pneumoniae septicaemia in neutropenic mice.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Neutropenia; Sepsis | 1986 |
Therapeutic efficacy of beta-lactam and aminoglycoside antibiotics on experimental pneumonia caused by Klebsiella pneumoniae B-54 in diabetic mice.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Experimental; Drug Resistance, Microbial; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Pneumonia | 1985 |